+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Respiratory Syncytial Virus Vaccine"

Respiratory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Respiratory Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 150 Pages
  • Global
From
mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
ABRYSVO Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

ABRYSVO Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Multivalent Vaccines Market 2024 - Product Thumbnail Image

Multivalent Vaccines Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 182 Pages
  • Global
From
Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • December 2023
  • 265 Pages
  • Global
From
Brazil Vaccine Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Thumbnail Image

Brazil Vaccine Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • June 2025
  • 250 Pages
  • Brazil
From
Japan Vaccine Market Report and Forecast 2025-2034 - Product Thumbnail Image

Japan Vaccine Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • Japan
From
Vaccine Adjuvant Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class, Type, and Geography - Product Thumbnail Image

Vaccine Adjuvant Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class, Type, and Geography

  • Report
  • January 2024
  • 155 Pages
  • Global
From
U.S. Respiratory Syncytial Virus Vaccines Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.) - Product Thumbnail Image

U.S. Respiratory Syncytial Virus Vaccines Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.)

  • Report
  • September 2024
  • 304 Pages
  • United States
From
Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast - Product Thumbnail Image

Global Respiratory Syncytial Virus Market Size and Epidemiology (8MM), By Drug Type (Synagis, Other), By Dosage Form (Oral, Other), By Treatment Type (Immune prophylaxis, Other), By Distribution Channel (Clinics, Other) -Estimation & Forecast

  • Report
  • June 2021
  • 675 Pages
  • Global
From
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 43 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Mucosal Vaccines. Innovation for Preventing Infectious Diseases - Product Thumbnail Image

Mucosal Vaccines. Innovation for Preventing Infectious Diseases

  • Book
  • October 2019
Plotkin's Vaccines. Edition No. 8 - Product Thumbnail Image

Plotkin's Vaccines. Edition No. 8

  • Book
  • May 2023
Loading Indicator

The Respiratory Syncytial Virus (RSV) Vaccine is a type of respiratory drug used to prevent infection from the RSV virus. It is typically administered to infants and young children, as well as to adults who are at high risk of developing severe RSV infection. The vaccine works by stimulating the body’s immune system to produce antibodies that can fight off the virus. It is usually given in two doses, with the second dose given one month after the first. The RSV Vaccine market is a growing sector of the respiratory drugs market. It is estimated that the global RSV Vaccine market will reach a value of over $1 billion by 2025. The market is driven by increasing awareness of the virus and its potential to cause severe illness, as well as the development of new vaccines. Some of the major companies in the RSV Vaccine market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Novavax. Show Less Read more